Dehydroretronecine-induced skin tumors in mice

Area of Science:

• Toxicology
• Carcinogenesis
• Dermatology

Background:

• Pyrrolizidine alkaloids are naturally occurring compounds found in various plants.
• Monocrotaline is a known pyrrolizidine alkaloid with toxic properties.
• Dehydroretronecine is a reactive metabolite of monocrotaline.

Purpose of the Study:

• To investigate the carcinogenic potential of dehydroretronecine.
• To determine if dehydroretronecine can induce skin tumors in mice.
• To assess dehydroretronecine as a proximate carcinogen.

Main Methods:

• Female Swiss mice were administered dehydroretronecine via subcutaneous injections and/or topical applications.
• Mice were observed for 15 months to monitor tumor development.
• Tumor incidence and type were recorded at the site of administration.

Main Results:

• A high incidence of tumors (63 out of 92 mice) was observed at the injection or application sites.
• Skin tumors, primarily basal cell and squamous cell carcinomas, were identified in 47 mice.
• Dehydroretronecine demonstrated significant tumorigenic activity at the site of exposure.

Conclusions:

• Dehydroretronecine acts as a proximate carcinogen.
• Dehydroretronecine induces a high rate of skin tumors in mice.
• The findings highlight the carcinogenic risk associated with dehydroretronecine exposure.